Title:
COMPOSITION CONTAINING MACROLACTIN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF FOOT-AND-MOUTH VIRUS INFECTIOUS DISEASE
Document Type and Number:
WIPO Patent Application WO/2022/250385
Kind Code:
A1
Abstract:
The present invention relates to a composition containing a macrolactin derivative or a pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of a foot-and-mouth virus infectious disease. The composition is identified to inhibit the gene expression of foot-and-mouth virus and suppress the proliferation of foot-and-mouth virus therethrough, thereby being expected to effectively cope with the spread of foot-and-mouth disease.
Inventors:
KANG JAE SEON (KR)
CHEONG JAE HUN (KR)
KANG HYO RIN (KR)
KIM HYUNG HOI (KR)
PARK MIN HI (KR)
HWANG SUNG WOO (KR)
LEE SEONG JAE (KR)
HWANG YE JIN (KR)
KIM HEON WOO (KR)
CHOI SI HOON (KR)
CHEONG JAE HUN (KR)
KANG HYO RIN (KR)
KIM HYUNG HOI (KR)
PARK MIN HI (KR)
HWANG SUNG WOO (KR)
LEE SEONG JAE (KR)
HWANG YE JIN (KR)
KIM HEON WOO (KR)
CHOI SI HOON (KR)
Application Number:
PCT/KR2022/007241
Publication Date:
December 01, 2022
Filing Date:
May 20, 2022
Export Citation:
Assignee:
KYUNGSUNG UNIV INDUSTRY COOPERATION FOUNDATION (KR)
AIINSIGHT INC (KR)
INSTITUTE FOR RES & INDUSTRY COOPERATION PNU (KR)
AIINSIGHT INC (KR)
INSTITUTE FOR RES & INDUSTRY COOPERATION PNU (KR)
International Classes:
A61K31/365; A23K20/126; A23K20/195; A61P31/14
Foreign References:
| KR20140016212A | 2014-02-07 | |||
| KR101070324B1 | 2011-10-06 | |||
| CN105126096A | 2015-12-09 |
Other References:
BELLO, T.R. ALLEN, T.: "The use of MicroLactin for inflammatory conditions in Equine Veterinary practice", JOURNAL OF EQUINE VETERINARY SCIENCE, vol. 25, no. 9, 1 September 2005 (2005-09-01), US , pages 380 - 382, XP005198664, ISSN: 0737-0806, DOI: 10.1016/j.jevs.2005.08.004
M. ROMERO-TABAREZ, JANSEN R., SYLLA M., LUNSDORF H., HAUSSLER S., SANTOSA D. A., TIMMIS K. N., MOLINARI G.: "7-O-Malonyl Macrolactin A, a New Macrolactin Antibiotic from Bacillus subtilis Active against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and a Small-Colony Variant of Burkholderia cepacia", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 50, no. 5, 1 May 2006 (2006-05-01), pages 1701 - 1709, XP055023677, ISSN: 0066-4804, DOI: 10.1128/AAC.50.5.1701-1709.2006
M. ROMERO-TABAREZ, JANSEN R., SYLLA M., LUNSDORF H., HAUSSLER S., SANTOSA D. A., TIMMIS K. N., MOLINARI G.: "7-O-Malonyl Macrolactin A, a New Macrolactin Antibiotic from Bacillus subtilis Active against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and a Small-Colony Variant of Burkholderia cepacia", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 50, no. 5, 1 May 2006 (2006-05-01), pages 1701 - 1709, XP055023677, ISSN: 0066-4804, DOI: 10.1128/AAC.50.5.1701-1709.2006
Attorney, Agent or Firm:
GHONG-GAN INTERNATIONAL PATENT LAW FIRM (KR)
Download PDF: